logo-loader

Canntab Therapeutics hoping to bring their slow release tablet tech to U.S.

Published: 21:53 04 Jun 2019 EDT

CannTab Therapeutics (CSE:PILL) CEO Jeff Renwick and Chief Financial officer Richard Goldstein sat down with Steve Darling from Proactive Investors at the LD Microcap conference in Los Angeles to talk about their company and their slow release tablets. They also chatted about the U.S. market and the potential for growth.

Rush Rare Metals Advances Two Key Projects: Uranium in Wyoming and Niobium...

Rush Rare Metals CEO Peter Smith joined Steve Darling from Proactive to share news about the mineral exploration company's focus on its Boxi Property in Quebec and the Copper Mountain Project in Wyoming. The company recently announced the staking of the Knob claims in Wyoming, comprising 52...

17 minutes ago